Industry / Brazil
Profarma Posts Strong Q208 Financial Results
August 2008 | Industry NewsBrazilian firm Profarma has announced that its consolidated gross revenue in Q208 has increased year-on-year by 21.8% to BRL742.8mn (US$476mn). The company's net income reached BRL6.6mn (US$4.23mn) in the Q208. The firm's market share reached 11.8% over the same period, increasing by 1.1 percentage
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
